The Stanford Biodesign Innovation Program, in cooperation with Windhover Information, Wilson Sonsini Goodrich & Rosati and PricewaterhouseCoopers presents a unique opportunity to hear our second special guest for the 2004 series Eberhard Grube, interviewed by David Cassak, Managing Partner, Windhover Information.
Eberhard Grube M.D. is a German cardiologist and visiting professor of cardiovascular medicine at Stanford University. He has been at the forefront of clinical research and technologies including drug eluding stents, total occlusion and current advances in congestive heart failure.
Dr. Grube has recently collaborated with the cardiovascular Core Analysis Laboratory in the observation of Intravascular Ultrasound (IVUS). He has been a pivotal player in the development and evaluation of leading medical technologies in the cardiovascular arena throughout the world.